Celsius Holdings, the Consumer Defensive sector company, was revisited by a Wall Street analyst yesterday. Analyst Anthony Vendetti from Maxim Group reiterated a Buy rating on the stock and has a $80.00 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Anthony Vendetti has given his Buy rating due to a combination of factors, primarily driven by Celsius Holdings’ strong financial performance and strategic partnerships. The company’s revenue and gross margin exceeded expectations in the third quarter of 2025, largely attributed to the impressive year-over-year growth of the Alani Nu brand. This growth, coupled with an increased market share in the ready-to-drink energy category, underscores the company’s robust market position.
Furthermore, the expanded partnership with PepsiCo is expected to enhance distribution capabilities and drive further growth. The anticipated integration of Alani Nu into the PepsiCo distribution system is likely to yield significant market share gains, with benefits expected to materialize in 2026. Despite potential short-term challenges, such as integration activities and promotional timing, the company’s innovation pipeline and targeted marketing strategies position it well for future success. Overall, Vendetti remains confident in Celsius Holdings’ ability to capitalize on opportunities in the expanding functional beverage market, justifying the Buy rating.
According to TipRanks, Vendetti is an analyst with an average return of -23.2% and a 25.86% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Dermata Therapeutics, Lucid Diagnostics, and Daxor.
In another report released today, Needham also reiterated a Buy rating on the stock with a $70.00 price target.